Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Raspberry and Reduced Fasting Blood Glucose Levels

Doses used in studies

mg/day: 180–200 (median 190, IQR 185–195) — 2 studies

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 2 of 2 studies

2 of 2 papers

The effects of ellagic acid in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: a randomized, add-on, double-blind, controlled trial.
- 2025-08-28
- RCT
- Inflammopharmacology 33(9)
- - Mohammad Mahmoudi Azar
  - Matin Shirazinia
  - Mohsen Nematy
  - Vafa Baradaran Rahimi
  - Motahare Bateni
  - Fateme Tafaghodi Piadeh Gheibi
  - Farnood Rajabzadeh
  - Ladan Goshayeshi
  - Sara Honari
  - Mehran Mottahedi
  - Vahid Reza Askari
- PubMed: 40877731
- DOI: 10.1007/s10787-025-01919-3
10 Insights on
- Reduced Fasting Blood Glucose Levels
- High evidence
- Clinical
fasting blood sugar (MD: - 6.78 mg/dL; P < 0.001)
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
200 mg once a day
A randomized double-blind clinical trial investigating the effects of ellagic acid on glycemic status, liver enzymes, and oxidative stress in patients with non-alcoholic fatty liver disease.
- 2025-01-30
- RCT · n = 44
- BMC complementary medicine and therapies 25(1)
- - Sara Mighani
  - Rasoul Samimi
  - Mohamadreza Rashidi Nooshabadi
  - Seyed Amir Farzam
  - Hossein Khadem Haghighian
  - Maryam Javadi
- PubMed: 39885430
- DOI: 10.1186/s12906-025-04759-4
14 Insights on
- Reduced Fasting Blood Glucose Levels
- High evidence
- Clinical
changes in high-density lipoprotein (HDL), total cholesterol (TC), and fasting blood sugar (FBS) were not significant in any of the groups (P > 0.05)
Effect
Neutral
Effect size
Small
Significant
No
Dose
180 mg per day